Skip navigation

Eli Lilly & Co.

NYS : LLY
Pharmaceuticals
Indianapolis IN
2013 Revenue (US$ Millions)$23,113
2012 Revenue (US$ Millions)$22,603
Revenue Growth (%)2.25%
Net Income (US$ Millions)$4,685
Common Shares Outstanding (Millions)$1,117
Earnings Per Share (US$)$4.32
Price To Earnings Ratio58.33
Total Equity (US$ Millions)$17,631
Profit Margin (%)20.27%
Return On Equity (%)31.73%
Long Term Debt (US$ Millions)$4,200
Debt To Equity Ratio (%)0.24%
Market Capitalization (US$ Millions)$56,957
Total Assets (US$ Millions)$35,249
Return on Assets (%)13.62
Current Assets (US$ Millions)$13,105
Inventories (US$ Millions)$2,929
Current Liabilities (US$ Millions)$8,917
Cost of Goods Sold (US$ Millions)$4,908
Asset Turnover0.66
Inventory Turnover1.76
ExchangeNYS